5 employees
Surface Pharmaceuticals is an owner and operator of a pharmaceutical company intended to provide ophthalmology products.
2017
$21M
from 2 investors over 2 rounds
Surface Ophthalmics, Inc. raised $21M on July 11, 2018
Investors: Visionary Venture Fund
Surface Ophthalmics, Inc. raised $20M on May 15, 2018
Investors: Flying L Partners